XOMA Royalty Corp. XOMA
Set alert
40.17 USD 0.00 0.00%
At close · Jul 13
42.15 +1.98 +4.93%
After hours · Jul 13, 4:00 PM ET
39.87 Day range 43.53
18.03 52-week range 35.00
- YTD
- +51.07%
- 1 year
- +47.04%
- Open
- 43.53
- Prev close
- 40.17
- Mkt cap
- 313.66M
- Vol
- 0
- Avg vol
- 29.44K
- EPS
- -3.07
- P/E
- 44.39
- Div yield
- 7.99%
More statistics
- Low
- 39.87
- High
- 43.53
- Forward P/E
- -56.64
- Beta
- 0.90
- Short ratio
- 3.33
- Inst. own
- 65.62%
- Dividend
- 2.16
- Ex-div date
- Jan 2, 2025
- 50-d avg
- 29.85
- 200-d avg
- 26.96
- 1y target
- 89.00
2Y chart
Events in this range
- Aug 13, 2024Earnings: -0.28; estimate -0.26; surprise -7.69%
- Aug 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Sep 20, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Oct 3, 2024Dividend: 0.53906
- Oct 23, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 7, 2024Earnings: -0.39; estimate -0.44; surprise 11.36%
- Dec 2, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 3, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Jan 3, 2025Dividend: 0.53906
Signals (104)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 2, 2026 | 4 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| RSI: Overbought | May 8, 2026 | 5 months ago |
| RSI: Overbought | May 5, 2026 | 5 months ago |
| RSI: Overbought | Apr 27, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| RSI: Overbought | Mar 31, 2026 | 7 months ago |
| SMA: Bullish | Mar 25, 2026 | 7 months ago |
| SMA: Bearish | Mar 24, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 6, 2026 | 7 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Mar 3, 2026 | 8 months ago |
| SMA: Bullish | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Feb 27, 2026 | 8 months ago |
| SMA: Bullish | Feb 24, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 19, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 6, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 3, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 15, 2026 | 9 months ago |
| SMA: Bullish | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 8, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 30, 2025 | 10 months ago |
| SMA: Bearish | Dec 11, 2025 | 10 months ago |
| SMA: Bearish | Dec 11, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 11, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 9, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 1, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 20, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 19, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 13, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| SMA: Bearish | Oct 17, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 6, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 3, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 17, 2025 | 1 year ago |
| RSI: Overbought | Sep 4, 2025 | 1 year ago |
| RSI: Overbought | Aug 19, 2025 | 1 year ago |
| SMA: Bullish | Aug 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 7, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 5, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 30, 2025 | 1 year ago |
| SMA: Bearish | Jul 30, 2025 | 1 year ago |
| SMA: Bullish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 24, 2025 | 1 year ago |
| SMA: Bearish | Jul 24, 2025 | 1 year ago |
| SMA: Bullish | Jul 23, 2025 | 1 year ago |
| SMA: Bullish | Jul 23, 2025 | 1 year ago |
| SMA: Bearish | Jul 18, 2025 | 1 year ago |
| SMA: Bearish | Jul 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 16, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 24, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 20, 2025 | 1 year ago |
| SMA: Bullish | Jun 18, 2025 | 1 year ago |
| SMA: Bearish | Jun 17, 2025 | 1 year ago |
| MACD: Sell Signal | May 22, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| RSI: Overbought | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 13, 2025 | 1 year ago |
| RSI: Overbought | May 13, 2025 | 1 year ago |
| RSI: Overbought | Apr 24, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 8, 2025 | 1 year ago |
| RSI: Oversold | Apr 8, 2025 | 1 year ago |
| RSI: Oversold | Apr 1, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Mar 13, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| RSI: Oversold | Feb 27, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 19, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 8, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 6, 2025 | 1 year ago |
| RSI: Oversold | Dec 18, 2024 | 1 year ago |
| SMA: Bearish | Dec 10, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 5, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 26, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 13, 2024 | 1 year ago |
| SMA: Bullish | Oct 11, 2024 | 2 years ago |
| SMA: Bearish | Oct 10, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 8, 2024 | 2 years ago |
| SMA: Bullish | Oct 4, 2024 | 2 years ago |
| SMA: Bearish | Oct 3, 2024 | 2 years ago |
| SMA: Bullish | Oct 2, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 23, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 19, 2024 | 2 years ago |
Key statistics
- Market cap
- 313.66M
- Enterprise value
- 295.82M
- Trailing P/E
- 0.00
- Forward P/E
- -56.64
- PEG ratio
- 0.00
- Price / sales
- 14.52
- Price / book
- 3.69
- EPS (TTM)
- -3.07
- Beta
- 0.90
- Dividend yield
- 7.99%
- Payout ratio
- 0.00%
- Profit margin
- -138.67%
- Revenue (TTM)
- 21.61M
- Revenue growth
- 767.10%
- Free cash flow
- -19.24M
- Total cash
- 142.84M
- Total debt
- 118.94M
- Return on equity
- -31.41%
- Shares outstanding
- 11.78M
- Short % of float
- 1.39%
- 50-day average
- 29.85
- 200-day average
- 26.96
Analyst view
Consensus: buy
Buy
Price target (mean) 89.00 +121.6% upside
Now 40.17
- Target (low)
- 55.00
- Target (mean)
- 89.00
- Target (high)
- 123.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy1
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
XOMA Revenue — quarterly 12.32M
XOMA Net income — quarterly 2.12M
XOMA EPS — quarterly 0.18
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.44 | -0.39 | +0.05 | +11.36% |
| Aug 13, 2024 | Jun 1, 2024 | -0.26 | -0.28 | -0.02 | -7.69% |
| May 9, 2024 | Mar 1, 2024 | -0.71 | -0.86 | -0.15 | -21.13% |
| Mar 8, 2024 | Dec 1, 2023 | -0.36 | -0.49 | -0.13 | -36.11% |
| Nov 7, 2023 | Sep 1, 2023 | -0.48 | -0.60 | -0.12 | -25.00% |
| Aug 8, 2023 | Jun 1, 2023 | -0.52 | -0.59 | -0.07 | -13.46% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Dec 3, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Dec 2, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 23, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Sep 20, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Aug 15, 2024 | HC Wainwright & Co. | main | Buy | Buy |
About XOMA Royalty Corp.
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- xoma.com
News
- This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday
- Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million
- XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday
- Ligand Pharmaceuticals To Acquire XOMA Royalty For $39.00 Per Share In Cash, Ligand Raises FY2026 Adj. EPS Guidance To $8.50-9.50 And Expects The Transaction To Be Accretive By $1.50 Per Share To Adj. EPS In 2027
- Earnings Scheduled For March 18, 2026
- XOMA Royalty Amends Its Collaboration, Originally Established In 2006, With Takeda Through Strategic Royalty Share Transaction
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Academy Sports and Outdoors, Tronox, STAAR Surgical And Other Big Stocks Moving Higher On Tuesday
- Stocks That Hit 52-Week Lows On Wednesday
Your note
Sign in to keep a note on XOMA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BURNS THOMAS M | Chief Financial Officer | Sale | Nov 12, 2024 | 20,107 |
| BVF PARTNERS L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 5, 2023 | 0 |
| HERNDAY NATASHA A | Director | Stock Award(Grant) | May 14, 2024 | 3,035 |
| HUGHES OWEN | Chief Executive Officer | Sale | Nov 12, 2024 | 34,979 |
| PERRY MATTHEW D | Director | Stock Award(Grant) | May 14, 2024 | 17,869 |
| SITKO BRADLEY J. | Chief Investment Officer | Purchase | Oct 2, 2023 | 7,100 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| BVF Inc. | 30.84% | 3,633,743 | 96.73M | Sep 29, 2024 |
| FMR, LLC | 9.36% | 1,102,401 | 29.35M | Sep 29, 2024 |
| Blackrock Inc. | 4.55% | 535,658 | 14.26M | Sep 29, 2024 |
| Vanguard Group Inc | 3.58% | 422,394 | 11.24M | Sep 29, 2024 |
| Opaleye Management Inc. | 2.12% | 250,000 | 6.66M | Sep 29, 2024 |
| Stonepine Capital Management, LLC | 1.66% | 195,096 | 5.19M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Capital Appreciation Fund | 2.51% | 296,000 | 7.88M | Oct 30, 2024 |
| Fidelity Advisor Equity Growth Fund | 2.47% | 290,628 | 7.74M | Oct 30, 2024 |
| Variable Insurance Products Fund-Growth Portfolio | 2.17% | 255,512 | 6.80M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.15% | 252,910 | 6.73M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.64% | 193,330 | 5.15M | Oct 30, 2024 |
| Fidelity Growth Discovery Fund | 1.25% | 147,667 | 3.93M | Oct 30, 2024 |